1,000 Shares in Colgate-Palmolive (NYSE:CL) Purchased by Cetera Trust Company N.A

Cetera Trust Company N.A bought a new position in shares of Colgate-Palmolive (NYSE:CL) in the 4th quarter, HoldingsChannel.com reports. The firm bought 1,000 shares of the company’s stock, valued at approximately $80,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. &PARTNERS grew its position in Colgate-Palmolive by 0.7% during the fourth quarter. &PARTNERS now owns 17,643 shares of the company’s stock worth $1,406,000 after buying an additional 129 shares in the last quarter. West Branch Capital LLC boosted its holdings in shares of Colgate-Palmolive by 24.0% in the 4th quarter. West Branch Capital LLC now owns 682 shares of the company’s stock worth $54,000 after purchasing an additional 132 shares in the last quarter. First Foundation Advisors boosted its holdings in shares of Colgate-Palmolive by 2.7% in the 3rd quarter. First Foundation Advisors now owns 5,226 shares of the company’s stock worth $372,000 after purchasing an additional 136 shares in the last quarter. Waldron Private Wealth LLC boosted its holdings in shares of Colgate-Palmolive by 2.7% in the 3rd quarter. Waldron Private Wealth LLC now owns 5,361 shares of the company’s stock worth $381,000 after purchasing an additional 140 shares in the last quarter. Finally, Autumn Glory Partners LLC boosted its holdings in shares of Colgate-Palmolive by 2.7% in the 4th quarter. Autumn Glory Partners LLC now owns 5,319 shares of the company’s stock worth $424,000 after purchasing an additional 140 shares in the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Trading Up 1.4 %

CL opened at $88.33 on Tuesday. The business has a 50 day simple moving average of $87.19 and a two-hundred day simple moving average of $81.06. The firm has a market capitalization of $72.61 billion, a price-to-earnings ratio of 31.77, a PEG ratio of 3.27 and a beta of 0.42. The company has a debt-to-equity ratio of 8.59, a current ratio of 1.11 and a quick ratio of 0.71. Colgate-Palmolive has a one year low of $67.62 and a one year high of $90.37.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, January 26th. The company reported $0.87 EPS for the quarter, beating analysts’ consensus estimates of $0.85 by $0.02. The business had revenue of $4.95 billion during the quarter, compared to analyst estimates of $4.89 billion. Colgate-Palmolive had a return on equity of 509.75% and a net margin of 11.82%. Colgate-Palmolive’s quarterly revenue was up 6.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.77 EPS. Analysts predict that Colgate-Palmolive will post 3.5 EPS for the current year.

Colgate-Palmolive Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd will be given a $0.50 dividend. The ex-dividend date of this dividend is Friday, April 19th. This represents a $2.00 annualized dividend and a dividend yield of 2.26%. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s dividend payout ratio is currently 71.94%.

Wall Street Analysts Forecast Growth

CL has been the subject of a number of research reports. UBS Group upped their price objective on Colgate-Palmolive from $93.00 to $95.00 and gave the stock a “buy” rating in a report on Monday, January 29th. Stifel Nicolaus upped their price objective on Colgate-Palmolive from $89.00 to $94.00 and gave the stock a “buy” rating in a report on Wednesday, April 10th. Barclays upped their price objective on Colgate-Palmolive from $82.00 to $84.00 and gave the stock an “equal weight” rating in a report on Friday, April 12th. TheStreet upgraded Colgate-Palmolive from a “c+” rating to a “b+” rating in a report on Friday, January 26th. Finally, Morgan Stanley boosted their target price on Colgate-Palmolive from $85.00 to $93.00 and gave the company an “overweight” rating in a research note on Monday, January 29th. Three equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $89.50.

Insider Transactions at Colgate-Palmolive

In other news, CEO Noel R. Wallace sold 50,000 shares of the stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $83.15, for a total value of $4,157,500.00. Following the completion of the transaction, the chief executive officer now owns 274,179 shares of the company’s stock, valued at approximately $22,797,983.85. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, Director C Martin Harris sold 2,760 shares of the stock in a transaction that occurred on Wednesday, January 31st. The stock was sold at an average price of $84.50, for a total value of $233,220.00. Following the completion of the transaction, the director now owns 19,272 shares of the company’s stock, valued at approximately $1,628,484. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Noel R. Wallace sold 50,000 shares of the stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $83.15, for a total value of $4,157,500.00. Following the completion of the transaction, the chief executive officer now directly owns 274,179 shares of the company’s stock, valued at approximately $22,797,983.85. The disclosure for this sale can be found here. In the last quarter, insiders sold 232,371 shares of company stock valued at $19,505,099. Corporate insiders own 0.37% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.